Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Budesonide and Surfactant Therapy Versus Surfactant Alone on Incidence of Lung Disease in Preterm Infants (BEST Lung): Study Protocol for a Systematic Review and Individual Participant Data Meta-Analysis With Nested Prospective Meta-Analysis.

Acta paediatrica (Oslo, Norway : 1992)·2026
Same author

Prognostic value of cervical length for spontaneous preterm birth in asymptomatic women with singleton pregnancy: An individual participant data meta-analysis.

PLoS medicine·2026
Same author

Population-Based Analysis of Rare Genetic Variants in Sudden Cardiac Arrest.

JACC. Clinical electrophysiology·2026
Same author

PhaseOne Hypochlorous Acid is Effective for Preventing Capsular Contracture and Infection in Primary Breast Augmentation.

Aesthetic surgery journal·2026
Same author

A Phase 1, Open-Label, Single Ascending (Two Levels) Dose Study to Evaluate the Pharmacokinetics of Vorasidenib in Healthy Japanese and Non-Asian Participants.

Journal of clinical pharmacology·2026
Same author

A quantitative approach for high-throughput mapping of collagen fibril orientation using polarization-dependent Second Harmonic Generation.

Acta biomaterialia·2026

Related Experiment Videos

Silymarin and hepatoprotection.

Frank J Burczynski1, Guqi Wang, David Nguyen

  • 1University of Manitoba, Winnipeg Manitoba R3E OT5, Canada. burczyn@cc.umanitoba.ca

Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences
|February 22, 2012
PubMed
Summary

Silymarin demonstrates hepatoprotective effects by reducing free radical damage and oxidative stress. This antioxidant compound also lowers pro-apoptotic Bax protein levels, suggesting its potential in treating liver diseases.

Related Experiment Videos

Area of Science:

  • Hepatoprotective agents
  • Oxidative stress research
  • Antioxidant mechanisms

Background:

  • Oxidative stress is a key factor in liver disease pathogenesis.
  • Free radical damage contributes to cellular injury and apoptosis in the liver.
  • Silymarin is a known antioxidant with potential therapeutic applications.

Purpose of the Study:

  • To evaluate the hepatoprotective effects of silymarin in cell cultures.
  • To investigate silymarin's antioxidant properties against oxidative stress.
  • To determine silymarin's impact on pro-apoptotic markers.

Main Methods:

  • Chang cell cultures were exposed to hydrogen peroxide (H2O2) to induce oxidative stress.
  • Intracellular free radical levels were measured using dichlorofluorescein (DCF) fluorescence.
  • Cell viability (MTT assay), ATP levels, and Bax expression were assessed to evaluate silymarin's protective effects.

Main Results:

  • Silymarin significantly reduced intracellular free radical levels (DCF fluorescence).
  • Silymarin treatment enhanced cell viability and ATP levels.
  • Silymarin administration led to reduced Bax protein and mRNA expression.

Conclusions:

  • Silymarin exhibits significant hepatoprotective effects against oxidative stress-induced free radical damage.
  • Silymarin's protective mechanism involves the reduction of pro-apoptotic Bax protein.
  • Silymarin shows promise as an adjuvant therapy for managing certain liver diseases.